| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC5339 | Unc6641 | Novel peptidomimetic antagonist of the PHF1 Tudor domain, binding both PHF1 Tudor domain and the related protein PHF19 |
|
| DCC5340 | Unc6864 | Novel inhibitor for histone methyllysine reader proteins (KmeRP), targeting CBX5 chromodomain |
|
| DCC5341 | Unc7040 | Novel potent and selective PAM of CBX8, blocking H3K27me3 binding and enhancing CBX8 affinity for nucleic acids, evicting PRC1 from H3K27me3 targets triggering DLBCL cell differentiation |
|
| DCC5342 | Unc9975 | Novel β-arrestin-biased D2 receptor (D2R) agonist |
|
| DCC5343 | Unipr500 Featured | Novel Eph antagonist, inhibiting Eph/ephrin interactions, enhancing glucose-stimulated insulin secretion (GSIS), and acting as a hypoglycemic agent |
|
| DCC5344 | Uodc14 | The first bifunctional (chemoreactive and clickable) probe for Adenosine A1 and A3 Receptors |
|
| DCC5345 | Upf-648 | Potent kynurenine 3-monooxygenase (kynurenine 3-hydroxylase; KMO) inhibitor |
|
| DCC5346 | Upg-100 | Novel superagonist of the urotensin-II (UT) receptor |
|
| DCC5347 | Upg-83 | Novel Potent antagonist of the Urotensin-II (UT) Receptor |
|
| DCC5348 | Upg-92 | Novel superagonist of the urotensin-II (UT) receptor |
|
| DCC5349 | Upg-95 | Novel potent antagonist of the Urotensin-II (UT) receptor |
|
| DCC5350 | Uproleselan | Novel E-Selectin antagonist, disrupting cell survival pathway activation, enhancing chemotherapy response and protecting from toxicity such as mucositis with improved survival in vivo |
|
| DCC5351 | Ur-ak1 | Novel Neuropeptide Y Y4 Receptor (Y4R) Antagonist (pK i values <7.57) |
|
| DCC5352 | Ur-ak32 | Novel Potent Neuropeptide Y Y4 Receptor (Y4R) Partial Agonist (pK i : 8.47) |
|
| DCC5353 | Uralenol-3-methylether | Natural flavonoid from the leaves of Glycyrrhiza uralensis |
|
| DCC5354 | Ur-ap164 | Novel Red-Emitting Fluorescent Dualsteric Probe for the Muscarinic Acetylcholine M2 Receptor |
|
| DCC5355 | Urb524 | Novel FAAH inhibitor |
|
| DCC5356 | Urb532 | Potent, selective, and irreversible inhibitor of fatty acid amide hydrolase (FAAH) |
|
| DCC5357 | Ur-deba148 | Novel potent partial agonist of histamine H4 receptors (H4R) |
|
| DCC5358 | Ur-deba176 | Novel potent partial agonist of histamine H4 receptors (H4R) |
|
| DCC5359 | Ur-deba242 | Py-5-Labeled Fluorescent Multipurpose Probe for Investigations on the Histamine H3 and H4 Receptors, acting as a partial agonist at the hH3R [pEC50 (reporter gene) 8.77] and as an inverse agonist/antagonist at the h/mH4Rs [pIC50 (reporter gene) 8.76/7.08; |
|
| DCC5360 | Ur-kat479 | Novel subtype selective histamine H2 receptor G protein-biased agonist |
|
| DCC5361 | Ur-mb-158 | Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo |
|
| DCC5362 | Ur-mb-159 | Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo |
|
| DCC5363 | Ur-mk299 | Novel NPY Y1 Receptor Antagonist |
|
| DCC5364 | Ur-nr266 | Novel fluorescent histamine H3 receptor ligand |
|
| DCC5365 | Ur-po563 | Novel H2 receptor agonist, functionally stimulating human cardiac H2 receptors in vitro and in vivo |
|
| DCC5366 | Usp30i | Novel USP30 inhibitor, increasing Ub-TOM20 with an EC50 of 2.45 mM and inducing the maximal Ub-TOM20 |
|
| DCC5367 | uta1inh | Novel kidney urea transporter UT-A1 inhibitor |
|
| DCC5368 | uta1inh-b1 | Novel |
|
